Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

NCT07085572 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia as lead sponsor.

NCT NCT07085572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07085572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer
Lead sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase
Phase 2
Overall status
Recruiting
Start date
September 18, 2025
Completion date
July 31, 2028
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal cortical carcinoma